Tiziana Life Sciences TLSA
NASDAQ TLSA
$0.62 +0.01 (+1.77%)
At close: Nov 11, 2026 · 4:00 PM EST

Tiziana Life Sciences (TLSA) Current Deferred Revenue (2025 - 2026)

Updated

Tiziana Life Sciences (TLSA) recorded Current Deferred Revenue of $343,000 in Q2 2026.

Analysis

Tiziana Life Sciences (TLSA) Current Deferred Revenue (2025 - 2026) Analysis & Trends

At the end of FY2025, Tiziana Life Sciences reported Current Deferred Revenue of $530,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Tiziana Life Sciences 73.51 Mn 55.35 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 343,000.00
Dec 31, 2025 530,000.00
API Access

Tiziana Life Sciences Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=TLSA&period=max&api_key=YOUR_API_KEY